Clinical Trial

Predictors of Clinically Relevant Hypotension and Hypoxemia During Propofol-Based Diagnostic Gastrointestinal Endoscopy

Study acronym: PRO-GI SAFE
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This prospective observational cohort study will evaluate the incidence and independent predictors of clinically relevant hypotension and hypoxemia during propofol-based diagnostic gastrointestinal endoscopy in adult patients at a tertiary referral hospital in Vietnam. Participants undergoing diagnostic upper gastrointestinal endoscopy, colonoscopy, or combined diagnostic procedures with propofol administration will be followed from pre-procedure assessment through the early recovery period. The study will assess demographic, clinical, airway, procedural, and sedation-related variables associated with clinically relevant cardiopulmonary adverse events.
Trial Details
NCT Number NCT07613073
Lead Sponsor Bach Mai Hospital
Conditions Hypotension, Hypoxemia
Enrollment 1,000 participants
Start Date 2026-05-15
Primary Completion 2026-10 (estimated)
Study Completion 2026-10-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-29